$25.5 Million

biote Corp.

Follow-on Offering

Bookrunner, January 2023

biote Corp.

biote Corp. (“Biote”) is transforming healthy aging through innovative, personalized hormone optimization therapies delivered by Biote-certified medical providers. Biote trains practitioners how to identify and treat early indicators of hormone-related aging conditions, an underserved $7 billion global market, providing affordable symptom relief for patients and driving clinic success for practitioners.